申请人:——
公开号:US20030144525A1
公开(公告)日:2003-07-31
The present invention relates to compounds of formulae
1
The compounds of the present invention are NMDA (N-methyl-D-aspartate)-receptor subtype blockers and are used in the treatment of diseases related to this receptor.
本发明涉及以下式1的化合物。本发明的化合物是NMDA(N-甲基-D-天冬氨酸)受体亚型阻断剂,用于治疗与该受体相关的疾病。